These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7949222)
1. Transient neonatal diabetes mellitus: a relapse after 10 years of complete remission. Vanelli M; De Fanti A; Cantoni S; Chiari G Acta Diabetol; 1994 Jun; 31(2):116-8. PubMed ID: 7949222 [TBL] [Abstract][Full Text] [Related]
2. "Lady-like": is there a latent autoimmune diabetes in the young? Lohmann T; Nietzschmann U; Kiess W Diabetes Care; 2000 Nov; 23(11):1707-8. PubMed ID: 11092301 [No Abstract] [Full Text] [Related]
3. Natural course of remission in IDDM during 1st yr after diagnosis. Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543 [TBL] [Abstract][Full Text] [Related]
4. Seven years of remission in a type I diabetic patient. Koivisto VA; Leirisalo-Repo M; Ebeling P; Tuominen JA; Knip M; Turunen U; Mandrup-Poulsen T; Pelkonen R Diabetes Care; 1993 Jul; 16(7):990-5. PubMed ID: 8359107 [TBL] [Abstract][Full Text] [Related]
6. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results. Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630 [TBL] [Abstract][Full Text] [Related]
7. Permanent diabetes without serological evidence of autoimmunity after transient neonatal diabetes. Gottschalk ME; Schatz DA; Clare-Salzler M; Kaufman DL; Ting GS; Geffner ME Diabetes Care; 1992 Oct; 15(10):1273-6. PubMed ID: 1425088 [TBL] [Abstract][Full Text] [Related]
8. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study. Kordonouri O; Danne T; Enders I; Weber B Eur J Pediatr; 1998 Mar; 157(3):202-7. PubMed ID: 9537486 [TBL] [Abstract][Full Text] [Related]
9. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885 [TBL] [Abstract][Full Text] [Related]
10. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739 [TBL] [Abstract][Full Text] [Related]
11. Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment. Karges B; Durinovic-Belló I; Heinze E; Boehm BO; Debatin KM; Karges W Diabetes Care; 2004 May; 27(5):1207-8. PubMed ID: 15111548 [No Abstract] [Full Text] [Related]
12. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients. Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202 [TBL] [Abstract][Full Text] [Related]
13. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes. Schölin A; Siegbahn A; Lind L; Berne C; Sundkvist G; Björk E; Karlsson FA; Diabetes Metab Res Rev; 2004; 20(3):205-10. PubMed ID: 15133751 [TBL] [Abstract][Full Text] [Related]
14. [Initial remission period in insulin-dependent diabetes in the young subject]. Vague P; Vialettes B; Lassmann V; Moulin JP Diabete Metab; 1985 Jun; 11(3):181-8. PubMed ID: 3928412 [TBL] [Abstract][Full Text] [Related]
15. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes. Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479 [TBL] [Abstract][Full Text] [Related]
17. Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes. Kohnert KD; Hehmke B; Keilacker H; Ziegler M; Emmrich F; Laube F; Michaelis D Int J Clin Lab Res; 1996; 26(1):55-9. PubMed ID: 8739857 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes. Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929 [TBL] [Abstract][Full Text] [Related]